Doctor's visit | price on request |
Bladder removal | $1500 - $2000 |
Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Read moreProfessor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.
He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977.
In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa.
Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University.
Current Positions:
In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009).
Publications: santoro%a - Search Results - PubMed (nih.gov)
Dr. C. Ramesh Kumar is a Urology and Renal Transplant Specialist with 28 years of experience. He is an expert in Erectile Dysfunction, Male Sexual Problems, H.I.V, Hydrocele Treatment (Surgical), and Vasectomy Surgery. He is a member of multiple medical societies and has published multiple research papers. He holds an MBBS from Madras Medical College, Chennai; MD, JJM Medical College, Davangere; and DNB, Urology, National board of examinations.
Read moreDr. C. Ramesh Kumar is a Urology and Renal Transplant Specialist with 28 years of experience. He is an expert in Erectile Dysfunction, Male Sexual Problems, H.I.V, Hydrocele Treatment (Surgical), and Vasectomy Surgery. He is a member of multiple medical societies and has published multiple research papers. He holds an MBBS from Madras Medical College, Chennai; MD, JJM Medical College, Davangere; and DNB, Urology, National board of examinations.
Chief Physician of Helios Hospital Berlin-Buch, Head of the Oncology and Palliative Medicine Department, Specialist in Radiotherapy.
Read moreChief Physician of Helios Hospital Berlin-Buch, Head of the Oncology and Palliative Medicine Department, Specialist in Radiotherapy.
Medical Oncology specialist with expertise in lung, breast, colorectal, gastric, liver, kidney, pancreatic, stomach, prostate, and uterine cancers. Experienced in chemotherapy, immunotherapy, phytotherapy, ozone therapy, hyperthermic chemotherapy, GIS cancer, and gynecological and genitourinary cancer. Member of the Turkish Oncology Group, Medical Oncology Association, Turkish Cancer Research and Warfare Association, European Society of Medical Oncology, European Society of Gynecologic Oncology, and International Association for the Study of Lung Cancer.
Read moreMedical Oncology specialist with expertise in lung, breast, colorectal, gastric, liver, kidney, pancreatic, stomach, prostate, and uterine cancers. Experienced in chemotherapy, immunotherapy, phytotherapy, ozone therapy, hyperthermic chemotherapy, GIS cancer, and gynecological and genitourinary cancer. Member of the Turkish Oncology Group, Medical Oncology Association, Turkish Cancer Research and Warfare Association, European Society of Medical Oncology, European Society of Gynecologic Oncology, and International Association for the Study of Lung Cancer.
The doctor is a Senior Researcher of the Department of Plastic and Reconstructive Oncourology of the National Cancer Institute in Ukraine and is a member of the European Association of Urology (EAU), American Urological Association (AUA), American Society of Clinical Oncologists (ASCO), Ukrainian Society of Urological Oncology (USAO), and International Association of Surgeons, Gastroenterologists, and Oncologists (IASGO). The doctor has authored 140 articles and 8 patents.
Read moreThe doctor is a Senior Researcher of the Department of Plastic and Reconstructive Oncourology of the National Cancer Institute in Ukraine and is a member of the European Association of Urology (EAU), American Urological Association (AUA), American Society of Clinical Oncologists (ASCO), Ukrainian Society of Urological Oncology (USAO), and International Association of Surgeons, Gastroenterologists, and Oncologists (IASGO). The doctor has authored 140 articles and 8 patents.
Dr. Alrawi is a highly qualified and experienced Board-certified Surgical Oncologist with expertise in upper gastrointestinal, head and neck, minimal invasive, breast, colorectal, and heated chemoperfusion oncology. He has held posts in tertiary referral cancer centers and is currently the Director of Oncology Services at VPS Hospital system in UAE & MENA. He is also involved in oncology research.
Read moreDr. Alrawi is a highly qualified and experienced Board-certified Surgical Oncologist with expertise in upper gastrointestinal, head and neck, minimal invasive, breast, colorectal, and heated chemoperfusion oncology. He has held posts in tertiary referral cancer centers and is currently the Director of Oncology Services at VPS Hospital system in UAE & MENA. He is also involved in oncology research.
Doctor's visit | price on request |
Immunotherapy with Keytruda (Pembolizumab) | $3200 - $4000 |
Dr. Shruti Kate is a highly trained and experienced oncologist, specializing in the treatment of different types of cancer, including lung, breast, and gynecological cancers. She has done extensive research in the field, and was the sole recipient of a travel award from India in the 2018 World Conference on Lung Cancer.
Read moreDr. Shruti Kate is a highly trained and experienced oncologist, specializing in the treatment of different types of cancer, including lung, breast, and gynecological cancers. She has done extensive research in the field, and was the sole recipient of a travel award from India in the 2018 World Conference on Lung Cancer.
Doctor's visit | price on request |
Immunotherapy with Keytruda (Pembolizumab) | $3200 - $4000 |
Doctor's visit | price on request |
Immunotherapy with Keytruda (Pembolizumab) | $3200 - $4000 |